What is the role of niacin (Vitamin B3) in the treatment of delirium tremens?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Niacin (vitamin B3) plays a supportive role in the treatment of delirium tremens (DTs) but is not a primary treatment. When treating alcohol withdrawal and DTs, thiamine (vitamin B1) supplementation is the essential vitamin therapy, typically given as 100 mg three times daily 1. Niacin should be administered as part of a comprehensive B-vitamin supplementation approach, usually at doses of 100 mg daily during alcohol withdrawal treatment. Niacin helps support proper brain function and metabolism during withdrawal, as chronic alcoholism often leads to nutritional deficiencies including niacin deficiency. While niacin deficiency can contribute to neuropsychiatric symptoms, the primary treatments for delirium tremens remain benzodiazepines (such as diazepam, lorazepam, or chlordiazepoxide) for symptom management and seizure prevention 1. Niacin supplementation should be viewed as an adjunctive nutritional support measure rather than a direct treatment for the acute symptoms of DTs. The physiological basis for niacin's role relates to its function as a precursor to NAD and NADP, coenzymes essential for cellular metabolism and energy production in the brain, which are often depleted in chronic alcoholism.

Some key points to consider:

  • Delirium is a common and serious condition that can be prevented and treated with a multidisciplinary approach 1.
  • Nutrition and hydration interventions have only shown efficacy in the prevention of delirium when they are part of multidisciplinary interventions 1.
  • Hospitalized older patients with present delirium should be screened for dehydration and malnutrition as potential causes or consequences of delirium 1.
  • Benzodiazepines are effective at providing sedation and potentially anxiolysis in the acute management of severe symptomatic distress associated with delirium 1.

Overall, while niacin plays a supportive role in the treatment of delirium tremens, it is not a primary treatment, and benzodiazepines remain the primary treatment for symptom management and seizure prevention. A comprehensive B-vitamin supplementation approach, including thiamine and niacin, is essential for supporting proper brain function and metabolism during withdrawal.

From the Research

Treatment of Delirium Tremens

The treatment of delirium tremens (DT) primarily involves the use of benzodiazepines, such as diazepam and lorazepam, due to their GABA-ergic effects 2, 3, 4. These medications are effective in controlling symptoms of DT, including agitation, autonomic instability, and hallucinations.

Role of Niacin (Vitamin B3)

There is no mention of niacin (Vitamin B3) in the treatment of delirium tremens in the provided studies 2, 3, 4, 5, 6. The focus of these studies is on the use of benzodiazepines, such as diazepam and lorazepam, as well as other medications like propofol, in the management of DT.

Alternative Treatments

In cases where benzodiazepines are not effective, other medications like propofol may be considered as an adjuvant therapy 5. However, the use of benzodiazepines remains the mainstay of treatment for DT.

Key Points

  • Benzodiazepines, such as diazepam and lorazepam, are the primary treatment for delirium tremens 2, 3, 4.
  • Niacin (Vitamin B3) is not mentioned as a treatment for delirium tremens in the provided studies.
  • Alternative treatments, like propofol, may be considered in refractory cases 5.
  • Further research is needed to determine the optimal treatment doses and strategies for delirium tremens 3, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Delirium Tremens: Assessment and Management.

Journal of clinical and experimental hepatology, 2018

Research

[Delirium tremens].

La Revue du praticien, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.